Health Care & Life Sciences » Pharmaceuticals | Jenburkt Pharmaceuticals Ltd.

Jenburkt Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
762
850
929
1,033
1,147
Cost of Goods Sold (COGS) incl. D&A
459
493
530
589
646
Gross Income
303
357
399
444
500
SG&A Expense
204
233
261
261
276
EBIT
99
124
138
-
224
Unusual Expense
-
-
-
-
-
Non Operating Income/Expense
3
3
9
2
4
Interest Expense
13
4
4
4
4
Pretax Income
103
143
168
205
253
Income Tax
28
47
60
70
81
Consolidated Net Income
75
96
108
135
172
Net Income
75
96
108
135
172
Net Income After Extraordinaries
75
96
108
135
172
Net Income Available to Common
75
96
108
135
172
EPS (Basic)
16.15
20.75
23.18
29.05
37.50
Basic Shares Outstanding
5
5
5
5
5
EPS (Diluted)
16.15
20.75
23.18
29.05
37.50
Diluted Shares Outstanding
5
5
5
5
5
EBITDA
115
151
158
200
239
Non-Operating Interest Income
13
20
25
28
29

About Jenburkt Pharmaceuticals

View Profile
Address
Nirmala Apartments, 93
Mumbai Maharashtra 400058
India
Employees -
Website http://www.jenburkt.com
Updated 09/14/2018
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. It offers anthelmintic, anti-osteoporotic, anti-arthritic, anti-ulcerants, antibiotics, aphrodisiac, anti-cough, and cold and allergy dermatological products. It operates through the Local and Exports segments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.